Esperion Therapeutics Inc (ESPR)
Operating Income Growth
70.22%
Quarterly · Period ending:
ESPR Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported70.22%period ending
Latest reported70.22%period ending
ESPR Quarterly Operating Income YoY % (-54.12% → 70.22%)
Year-over-year change
High-resolution chart · PNG
ESPR operating income growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Income Growth |
|---|---|
| 70.2163% | |
| 2,028.3484% | |
| 37.8572% | |
| 175.1066% | |
| -130.5747% | |
| 89.5674% | |
| 41.7935% | |
| 106.9594% | |
| 248.6863% | |
| 0.3434% | |
| 33.8515% | |
| 29.2462% | |
| -13.0638% | |
| 23.5763% | |
| 25.3332% | |
| -60.9935% | |
| 48.096% | |
| 41.7928% | |
| 30.7954% | |
| -125.1862% | |
| -11.2538% | |
| -62.0803% | |
| -22.4775% | |
| 333.5889% | |
| -185.64% | |
| 2.7783% | |
| -30.074% | |
| -18.9716% | |
| 285.3734% | |
| -56.732% | |
| -10.5494% | |
| -6.459% | |
| -14.6861% | |
| -32.1359% | |
| -158.2261% | |
| -204.6542% | |
| -175.867% | |
| -121.2861% | |
| -37.1004% | |
| -14.9976% | |
| -29.733% | |
| -41.0874% | |
| -33.1856% | |
| -34.6661% | |
| -44.8035% | |
| 3.6567% | |
| -79.403% | |
| -116.6276% | |
| -135.9441% | |
| -350.7317% | |
| -80.8151% | |
| -49.1629% | |
| -52.7237% | |
| 12.2938% | |
| -7.2132% | |
| 3.551% | |
| 6.826% | |
| -9.0057% | |
| 18.25% | |
| 18.8831% | |
| -15.7098% | |
| 21.2609% | |
| -16.3672% | |
| -54.12% |